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5-S-Cysteinyldopa (5-S-CD) is found in all pigment-pro-
ducing cells and is the major precursor of phaeomelanin. 
However, the melanocyte specificity of the compound has 
been guestioned. In order to elucidate the origin of 5-S-CD, 
we have now systematically studied the relationship between 
the 5-S-CD excretion in urine and the size of the melanocyte 
organ, UV-induced melanocyte proliferation, skin type, and 
the erythemal reaction. The skin type had no influence on 
the basal excretion of 5-S-CD. There was no significant cor-
relation between the basal 5-S-CD excretion and the size of 
the melanocyte organ; that is, the number of skin melano-
T he phaeomelanin precursor 5-S-cysteinyldopa (5-S-CD) is formed in melanocytes by the addition of cys-teine to dopaquinone [1]. Some of the 5-S-CD in the cytoplasm seems to be released to the extracellular space, where it reaches the circulation, and is finally 
excreted in urine [2,3J. 
5-S-CD has been used as a tumor marker for malignant mela-
noma for several years [4]. As more se nsitive allalytical methods 
were dev<;loped, analysis of 5-S-CD could also be used to elucidate 
pigment formation and metabolism in the normal melanocytes. 
Some of these studies have disclosed unexpected findings not in 
keeping with the general view that the 5-S-CD excretion mainly 
reflects melanocyte activity. The basal 5-S-CD excretion has, for 
example, been shown to be independent of skin color [5,6J. Even 
more surprising are the findings of a normal 5-S-CD excretion in 
both tyrosinase-positive and negative albinos [7,8]. Furthermore , 
free and protein-bound 5-S-CD have been found in several other 
organs in mice, rats, and guinea-pigs [9, 10J. If the excreted 5-S-CD 
is mainly melanocyte derived, one would expect a correlation be-
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cytes and nevi. During the irradiation, subjects with skin type 
II developed a more pronounced erythema (p < 0.01) and 
had a significantly higher 5-S-CD excretion than those wit4 
skin type III-IV (p < 0.01). No correlation was found be, 
tween 5-S-CD excretion and UV-induced melanocyte pro, 
liferation. The lack of correlation between the basal 5-S-CD 
excretion and skin type or number of melanocytes suggests 
that the basal 5-S-CD in urine is mainly of extra-melanocytic 
origin. Our findings favor the view that tbe increase in 5-S, 
CD excretion during UV irradiation is due to UV damage.] 
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tween 5-S-CD levels and the size of the melanocyte organ; that is, 
the number of epidermal melanocytes and nevi. However, the influ_ 
ence of the size of the melanocyte organ on the 5-S-CD excretion 
has never been investigated. 
It is we ll known that sun exposure increases the 5-S-CD excre, 
tion in urine. The highest excretion values have been found in 
subjects with a tendency to burn .easi ly and tan poorly [11]. The 
hypothesis that the UV -induced 5-S-CD increase is due to melano-
cyte injury and not to the level of pigment production has therefore 
been suggested. Another interesting observation is a delayed in-
crease in 5-S-CD excretion following PUV A (8-methoxy-psoralen 
and UV A light) treatment of very limited skin areas. This was 
suggested to be due to systemic effects of UV light [12]. 
To obtain a better understanding of the origin of the 5-S-CD and 
the mechanisms behind the UV -induced increase, we decided to 
analyze th e 5-S-CD excretion in relation to the following variables: 
skin type as defined by Melski [13], basal epidermal melanocyte 
population density, UV-induced erythema, and, finally, melano-
cyte proliferation in UV-exposed and shielded skin. If any correla-
tion was found, it would be possible to individualize the excretion 
levels of 5-S-CD and make it a more reliable tumor marker even 
during the sunny season. 
MATERIALS AND METHODS 
The investigation was performed during the winter season in Swe-
den (from January to April). None of the participants had been 
exposed to strong sun light or any artificial ultraviolet li ght during a 
period of three months preceding the study. In order to avoid expo-
sure to sunlight during the experimenta l period, the participants 
were instructed to avoid outdoor activities. 
Subjects Twenty healthy volunteers, 12 women and 8 men aged 
26 - 49 years with skin type 1I - IV, took part in the study. Hair and 
eye color and number of nevi were registered. Body surface area was 
estimated from height and weight using a nomogram based 011 the 
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formula proposed by Du Bois [14]. Details of the subjects' status are 
given in Table I. 
UVB Irradiation The light source was a Philips TL12 UVB-box 
w ith an emission spectrum of 270-380 nm (peak 305 nm). The 
light intensity in the UVE region was measured with an IL 1350 
photometer (International Light, Inc.) with a sensitivity of 245-
355 nm and a maximum at 291 nm. 
All subjects received total body UVB irradiation three times 
weekly during 17 d (Fig 1). The dose was the same for all individ-
uals and was increased to give a slight erythema for skin type II at all 
exposures. The eight doses were 24, 32, 32, 40, 56,72,88, and 104 
mJ/cm2• 
During irradiation, a 15 X 15 cm area on the left buttock was 
shielded with black plastic tested to be non-transmitting for the UV 
light used. After each irradiation, the erythema of the skin was 
graded by the subjects as none, slight, moderate, or severe. In the 
statistical analysis, the erythemal reaction was scored as 0, 1,2, or 3. 
Skin Biopsies Before starting the irradiation, a 3-mm punch 
biopsy was taken from the left buttock skin. Three weeks after the 
last UV exposure, another biopsy was taken from the shielded left 
buttock and a third from the exposed right buttock area. The skin 
specimens were incubated with NaBr and the epidermis was sepa-
rated from the dermis. After DOPA incubation, the epidermal mel-
anocyte population density was estimated using a random dot pro-
cedure [15,16]. 
In each biopsy, 40 to 60 ocular fields were counted on coded slides 
using a X 40 objective. Correction was made for the change in size 
of the skin biopsy during preparation. 
The number of melanocytes varies over the body surface but is 
reasonably uniform over the trunk and extremities. We have there-
fore assumed that the counts from the buttock skin were representa-
tive of the melanocyte population in the larger skin areas. Biopsy 
counts times body surface area were used as a relative measure of the 
total epidermal melanocyte mass [16] . 
Urine Sampling and 5-S-CD Analysis Before entry to the 
study and twice weekly until day 38, the 24-h urine production was 
collected in plastic bottles containing 5 ml of thymol (0.7 mol/I) in 
isopropanol and stored at -20°C unti l analysis. The stability of 
5-S-CD at this temperature was verified by repeated analysis of two 
urinary samples, which showed constant values for two years. The 
5-S-CD concentration was determined by high-performance liquid 
chromatography [17]. 
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Figure 1. Mean 5-S-CD excretion (± SEM) (n = 20) . Arrows indicate 
UVB exposure. Slraded area: mean basal 5-S-CD level ± SEM. 
Calculations The UV-induced increase of 5-S-CD excretion 
over a period of time was measured as the area between the baseline 
and the excretion curve with standardized scales on the x-axis (24 h) 
and y-axis (/1mo1/24 h) . This area was measured by means of a 
computer-based interactive image-analysis system (IBAS IIII, Kon-
tron Bildanalyse GmbH) and expressed in arbitrary area units 
(AAU) . All values we,re normalized for the variation in body surface 
area. 
Statistical analysis was performed with Pitman's T est (1 8). All 
p-values given are valid for two-tailed tests . 
RESULTS 
Basal 5-S-CD in Urine Table II presents the mean basal excre-
tion values of 5-S-CD for men, women, and the different skin types. 
There was no significant difference in 5-S-CD output between the 
sexes. Subjects with skin type II excreted the same amount of 5-S-
CD as subjects with skin type III - IV, despite the difference in 
pigment production and phaeomelanin content between the two 
groups. 
If the 5-S-CD in urine mainly originates from the epidermal 
melanocytes, there should be a correlation between the total num-
ber of skin melanocytes and the amount of 5-S-CD excreted. The 
melanocyte population density per ocular field in the control biopsy 
Table I. Individual Basal Data on all Participants. 
Basal 5-S-CD Jlmol/24 h/m2 Basal 5-S-CD Jll11ol/ mol Melanocyte population density 
Sex Age Skin type body surface creatinine before irradiation 
F 41 II 0.15 30 3.1 
F 34 II 0.24 34 2.8 
F 36 II 0.15 26 2.3 
F 29 II 0.07 10 2.6 
F 40 II 0.19 26 5.3 
F 43 II 0.16 32 1.4 
F 26 II 0.24 41 2.2 
F 26 II 0.26 36 3.2 
M 30 II 0.1 7 25 2.0 
M 37 II 0.14 21 3.0 
M 28 II 0.24 31 
F 41 JII 0.19 35 2.5 
F 49 III 0.23 31 4.4 
F 46 III 0.14 28 3.6 
M 34 JII 0.18 27 2.0 
M 39 III 0.18 21 1.3 
M 36 III 0.22 31 2.6 
M 39 JII 0.18 22 3.2 
F 43 IV 0.21 35 3.6 
M 49 IV 0.23 34 3.2 
Mean ± SEM 0.1 9 ± O.ot 29 ± 2 2.9 ± 0.2 
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Table II. Basal Urinary 5-S-CD (mean ± SEM) in Relation to Sex, Skin type, and Number of N evi. 
Basa l 5-S-CD in urine 
-----------------------------------------------------
Jlmol/24 h Jlmol/24 h/ m2 body surface Jlmol/mol creatinine 
Women (n = 12) 
Men (n = 8) 
0.31 ±0.03 0.19 ±0.02 
0.38 ± 0.02 0.19 ± 0.01 
Skin type \I (n = 11) 0.32 ± 0.03 0.18 ± 0.02 
Skin type Ill-IV (n = 9) 
Number of nevi < 10 (n = 11) 
Number of nevi 10 - 50 (n = 9) 
0.36 ± 0.02 0.20 ± 0.01 
0.36 ± 0.02 0.19 ± 0.01 
0.31 ± 0.04 0.18 ± 0.02 
ranged from 1.3 to 5.3, with a mean (± SEM) of 2.9 (± 0.2), 
Table I. 
The mean va lue of the melanocyte population density was the 
same in skin type II (2.8 ± 0.3) and skin type III-IV (2.9 ± 0.3) . 
N o correlation was found between the 5-S-CD excretion and the 
total number of skin melanocytes. 
Another part of the melanocyte organ comprises the pigment 
cell s in nevi. N one of the participants had more than 50 nevi and 11 
had less than 10. Of the nine subjects w ith 10 - 50 nevi, eight had 
skin type II. There was 110 correl ation between the individual 5-S-
CD output during 24 h and the number of nevi (Table II). 
UVB-Induced Increase of 5-S-CD in Urine In the following 
presentation the data on 5-S-C D are expressed per m2 body surface 
area to normalize for the differences in skin area exposed to UVB. 
The mean (± SEM) 5-S-CD excretion increased continuously 
during UVB stimulation to reach a maximum of 0.45 (± 0 .04) 
Jlmol/m2 on day 17, approximatel y twice the basal value (0.19 ± 
0.01 ,umol/m2) (Fig 1). 
After cessation of the irradiation, the mean excretion decreased 
but did not return to the basal level during a 3-week follow-up 
period. 
When individual curves were studied, different excretion pat-
terns were identified. On average, subjects with skin type II reached 
their peal( 5-S-CD excretion on day 13 (Figs 2 and 3), whereas 
subjects w ith skin type III - IV reached their mean maximum on day 
17 (Figs 2 and 3). This difference might be due to the variation in 
UV dose absorbed. In two subjects, no well-defin ed peak was regis-
tered. In seven of the 20 subjects, a second (and in one case even a 
third 5-S-CD) peak was registered durin g the follow-up period 
(Figs 2 and 3). Three of them had skin type II and four had skin type 
III - IV. In some su bjects, the second peak was even higher chan the 
fi rst peak registered during the UVB stimulation . There was no 
correlation between the presence of a second 5-S-CD peak and the 
melanocyte proliferation in irradiated or shielded skin. 
To be able to analyze the 5-S-CD excretion during the irradiation 
and fol low-up period separately, we divided the excretion curve 
into two phases: phase I representing the acute reaction to UVB 
stimulation and phase II from day 24 describing an indirect or de-
layed reaction to UVB. 
To analyze the UVB- induced increase in 5-S-CD excretion over 
a period of time independent of the basal excretion , we calcul ated 
the area between the basal level and the excretion curve. During 
phase I, subjects with skin type II had a larger increase in 5-S-CD 
excretion than those with skin type III - IV. The mean (± SEM) area 
describing the 5-S-CD increase during phase I was 115 (± 18) AAU 
for skin type II and 53 (± 8) AAU for skin type III - IV (p < 0.01) 
(Fig 4). 
.. 
'" ;U
1.0 
~ 0 .8 
~ 
~ 
>-
g 0 .6 
D 
'" 12 
.c 
~ 0 .4 
'0 
E 
:l., 
e 0 .2 
I 
<JJ 
I 
II) 
A 
o • •• •• 
.. 
'" ;U
1.0 
~ 0 .8 
.. 
~ i 06 
'" 12 
.c 
.. 0 .4 
'" t S 0.2 
I 
<JJ 
I 
II) 
o 
B 
o • •• •• 
.. 
'" ;u
1.0 
e 0.8 
.. 
't: 
::J 
'" >-] 0 .6 
'" ~ 
.c 
... 0 .4 
~ 
'0 
E 
:J... 
S 0 2 
\ 
<JJ 
I 
II) 
o 
c 
2 
2 
As expected, subjects with sk in type II developed a more pro-
nounced erytbemal reaction than those with skin type III - IV. Tbe 
accumulated mean (± SEM) erythemal score was 9.0 (± 1.3) for 
skin type II and 2.8 (± 0.9) for skin type III - IV (p < 0.01). The 
number of melanocytes in th e control biopsy before irradiation was 
not correlated co the erythemal reaction, nor to the increase of 
5-S-CD excretion during ph ase 1 (Fig 5). 
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D uring phase II , the mean 5-S-CD excretion was identical for the 
two groups, 20 ± 6 AA U for skin type II and 19 ± 8 AA U for skin 
type III - IV. This phase was characterized by a mean 5-S-CD excre-
Figure 2. Individual curves representing characteristic 5-S-CD excretion 
patterns; Fig. 2A skin type II, 2D skin type III and 2C skin type II with a 
second peak. Arrows indicate UVB exposure. 
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Figure 3. The occurrence of individual 5-S-CD peaks. Roman numerals 
ind icate skin type. Two subjects had no well-defined peaks and are excluded 
from this figure . One subject had the same excretion level on days 6 and 13. 
In the remaining subjects, the time for the first peak varied from day 10 to 17 
fo r skin type II and from day 17 to 20 for skin type Ill - IV. 
tion sli ghtly above th e basal values, with occasional peaks (Fig 1) . 
This could reflect an UV - induced increase in the number of act ive 
melanocytes, because there was a doubling of the melanocyte popu-
lation in irradiated skin on day 37. However, there w as no correla-
tion between the individual values for 5-S-CD excretion during 
phase I + II and the increase in melanocyte number (Fig 6). A sig-
nificant increase in the number of melanocytes was also found in the 
biopsy from shielded skin. The systemically induced melanocyte 
proliferatio n was, however, not significantly correlated to the 5-S-
CD excre tion during phase I or II whe n individua l values were 
a nalyzed. 
DISCUSSION 
5-S-Cysteinyldopa is found in a ll pigment-producing cells and is th e 
major precursor of phaeomelanin. The melanocyte specificity of 
0.60 
:: i 0.50 
~ 
~ 
.. 0 40 j' 
1 0.30 
... 
'" ::, l O.20 
~ 
J, 0.10 
a 
a 
Phase I Pha ... I 
• • • • 
2 3 5 weeks 
Figure 4. UVB-induced increase of 5-S-CD excretion in subjects with skin 
type II (0 ) (n = 11) and skin type III - IV (e) (n = 9), mean ± SEM. Arrows 
indicate UVB exposure . 
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Figure 5. Sca tter diagram of melanocyte population density before irradia-
tion and 5-S-C D excretion durin g phase I, normalized for body surface area. 
this compound h as la'te ly been questioned [6,8,10]. W e h ave now 
systematically studied the relationship between urinary excretion of 
5-S-CD and the size of th e melanocyte organ, UV - induced melano-
cyte proliferation, skin type, and the erythemal reac tion. No corre-
lation w as found between the basal 5-S-CD excretion and the vari-
ab les studied. 
The epidermal m.elanocytes constitute the dominant part of the 
m elanocyte organ [16] . They are evenly distributed over the larger 
skin areas, and the interindividual variation found in the buttock 
skin is considered to be expressed over th e whole body surface. We 
h ave therefore assumed that the buttock skin counts are representa-
t ive o f the melanocyte population d ensity in the m ajor part of the 
inte gument. The observed m elanocyte population varied by a factor 
of four between individuals. However , if the three m ost extrem e 
values were eliminated, the remaining counts varied by a factor of 
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Figure 6. Scatter diagram of melanocyte population density increase in 
exposed skin and 5-S-CD excretion during phase I + II , normalized for 
body surface arca. 
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two, which is comparable with the interindividual variations ex-
pected [19]. There was no correlation between the melanocyte pop-
ulation densiry X body surface area and the basal 5-S-CD excretion. 
This indicates that it will not be possible to make 5-S-CD a more 
sensitive tumor marker by compensating for individual differences 
in the basal melanocyte mass. 
The classification of skin rypes as defined by Melski is based on 
the reaction to UV light. Our subjects with skin type II were also 
generally fair-skinned, red-haired or blond. Subjects with skin type 
III - IV had generally darker skin and hair. In agreement with a 
previous report [6], we found no difference in basal 5-S-CD excre-
tion between the two groups. This adds further support to the view 
that the basal 5-S-CD is not exclusively derived from the melano-
cytes. 
After UV irradiation, the melanocytes increased their melanin 
production, as evident from the skin tanning. In addition, UV light 
induced melanocyte proliferation. It has generally been assumed 
that the increase in S-S-CD during UV exposure is due to stimula-
tion of melanogenesis, but the possibility ofUV-induced damage to 
the melanocyte has also been suggested. We found no correlation 
between the S-S-CD excretion and the number of skin melanocytes 
before or after UV irradiation. Furthermore, subjects with skin type 
II, who generally tan poorly, demonstrated a significantly greater 
increase in 5-S-CD during UVB irradiation than subjects with skin 
type III - IV. 
5-S-CD might not just be a precursor to phaeomelanin but may 
also represent a pathway to protect the cells from the toxic effects of 
dopaquinone [20]. Such mechanism might explain why the fair-
skinned subjects who received a higher biologic UV dose in the 
target cells demonstrated significantly higher excretion values than 
those with skin type III - IV. UV -induced melanocyte injury might 
also lead to an increased leakage of this compound from the cells. 
Furthermore, the pronounced erythemal reaction with an enhanced 
dermal circulation might contribute to an increased clearance of 
S-S-CD from the extracellular space. 
It cannot be excluded that a pronounced inflammatory reaction in 
the skin might also have indirect effects on non-melanocytic sys-
tems capable of synthesising 5-S-CD. 
After cessation of the irradiation, the mean 5-S-CD excretion 
decreased but did not reach the basal values. Seven of twenty sub-
jects developed a significant peak in 5-S-CD excretion during this 
follow-up period (phase II). These seven subjects had not acciden-
tally been exposed to sunlight. Due to th e short duration of these 
peaks, we might have failed to register this event in additional 
subjects. Similar second urinary S-S-CD peaks have been reported 
during PUVA treatment [21,22] . A delayed 5-S-CD reak in serum 
has also been registered during PUV A treatment 0 very limited 
skin areas [1 2]. 
The previously reported second peaks occurred during continua-
tion of the irradiation. In this study, the second peaks were noted at 
the same point of time even though the irradiation period was 
terminated. This demonstrates that the delayed 5-S-CD increase is 
independent of ongoing irradiation and supports the concept of an 
indirect effect of UV light. However, in our subjects with second 
peaks there was no correlation between the 5-S-CD levels during 
phase II and the melanocyte proliferation in shielded skin or in 
irradiated skin. To verify or exclude the possibility that this obser-
vation reflects a synchronized melanocyte proliferation or cell death 
it is necessary to make more frequent 5-S-CD analyses and melano-
cyte counts. 
In this study we have not been able to demonstrate any correlation 
between the basal 5-S-CD excretion and the number of melano-
cytes. This is in line with the view that the basal 5-S-CD in urine is 
also derived from other sources than skin me1anocytes. 
Our findings during UV irradiation favor the view that the in-
crease in 5-S-CD excretion is due to damage to the melanocytes. 
5-S-CD is so far the best mel anoma tumor marker. Unfortunately, 
our results excl ude the possibility of improving its diagnostic sensi-
tivity by compensating for differences in basal melanocyte mass or 
UV -induced melanocyte proliferation. 
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